6-K ·Filed Jun 16, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor for subsequent filings (e.g., 6-K or 8-K) that may contain actual financial results, clinical trial updates, or capital market activities. The current filing provides no actionable information.
Final — all horizons settled through T+60d
ATHE ▼ -11.61% at T+60d
NEUTRAL call -11.61% · α vs SPY -12.61% · entry $4.65 → $4.11
T+1d
+10.54%
call +10.54% · α +11.79%
$5.14
settled 4mo ago
T+5d
+6.67%
call +6.67% · α +8.90%
$4.96
settled 4mo ago
T+20d
+8.17%
call +8.17% · α +7.97%
$5.03
settled 3mo ago
T+60d
-11.61%
call -11.61% · α -12.61%
$4.11
settled 7w ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. Alterity Therapeutics filed a Form 6-K furnishing a corporate presentation for June 2026. The presentation slides are image files with no extractable text, so no material financial data, clinical updates, or guidance changes can be confirmed.
Key Facts
- Filing is a routine 6-K furnishing a corporate presentation as Exhibit 99.1.
- Presentation slides are provided as image files (JPEG) with no readable text content.
- No financial figures, clinical data, or forward-looking statements are extractable from the filing.
Financial Impact
Not specified
Risk Factors
- Lack of transparency in presentation content may indicate no material new information.
- OTC-listed micro-cap with low liquidity; any news could cause disproportionate price moves.
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
80% bullish (5 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-020725 |
| Document: athe20260616_6k.htm | 0001437749-26-020725 |
| Document: 0001437749-26-020725-index-headers.html | 0001437749-26-020725 |
| Document: 0001437749-26-020725-index.html | 0001437749-26-020725 |
| Document: 0001437749-26-020725.txt | 0001437749-26-020725 |
42 reports for ATHE
67% Hit rate @ T+60 Went positive at some point 10 of 10 best @ T+20▲ +27.97%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (+0.48%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (−0.48%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (−0.48%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.08 (−12.97%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.08 (−12.97%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.08 (−14.40%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.08 (−33.33%) |
Oct 5, 2026 21d ago | Press Release | $3.22 | awaiting T+60 | — | $2.08 (−35.40%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.08 (−35.40%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.08 (−43.32%) |
Showing 10 of 42
US Market Status
Market Closed — Opens in 2h 32m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers